SWITCHING FROM ETANERCEPT ORIGINAL TO ETANERCEPT BIOSIMILAR. EXPERIENCE IN A TERTIARY HOSPITAL.

被引:0
|
作者
Aldasoro, V. [1 ]
Mendizabal, J. [1 ]
Perez Garcia, S. [1 ]
Sada Urmeneta, G. [1 ]
Restrepo Velez, J. [1 ]
Del Val Del Amo, N. [1 ]
Paniagua Zudaire, I. [1 ]
Gutierrez Polo, R. [1 ]
Horcada, L. [1 ]
Garrido Courel, L. [1 ]
Fito-Manteca, C. [1 ]
机构
[1] Navarra Univ Complex, Rheumatol, Pamplona, Spain
关键词
D O I
10.1136/annrheumdis-2020-eular.3279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0272
引用
收藏
页码:1430 / 1431
页数:2
相关论文
共 50 条
  • [1] SWITCHING FROM ETANERCEPT ORIGINAL TO ETANERCEPT BIOSIMILAR: LONG TERM FOLLOW UP
    Sada, G.
    Pineiro, M. C. Laino
    Aldasoro, V.
    Mendizabal, J.
    Lopez, M.
    Perez, S. Garcia
    Cottrell, L. Garrido
    Del -Val, N.
    Horcada, L.
    Polo, R. Gutierrez
    Zudaire, I. Paniagua
    Fito-Manteca', C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1132 - 1132
  • [2] SWITCHING FROM ENBREL TO ETANERCEPT BIOSIMILAR (BENEPALI). EXPERIENCE IN TWO TERTIARY HOSPITALS
    Aldasoro Caceres, Vicente
    Lamua Riazuelo, Jose Ramon
    Mendizabal Mateo, Javier
    Perez Gacia, Sara
    Sada Urmeneta, Guillen
    Restrepo Velez, Juliana
    Garrido Courel, Laura
    Gutierrez Polo, Ricardo
    Paniagua Zudaire, Inmaculada
    del Val del Amo, Natividad
    Horcada Rubio, Loreto
    Fito Manteca, Concepcion
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 69 - 70
  • [3] SWITCHING FROM BIO-ORIGINAL ETANERCEPT TO BIOSIMILAR ETANERCEPT SB4: PATIENT ACCEPTABILITY AND OUTCOMES IN THE REAL WORLD
    Holroyd, C.
    Wallis, D.
    Bennett, S.
    Clayton, P.
    Edwards, C. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1180 - 1180
  • [4] Doctor's aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center
    Al Tabaa, Omar
    Etcheto, Adrien
    Dumas, Sophie
    Batteux, Frederic
    Goulvestre, Claire
    Molto, Anna
    Miceli-Richard, Corinne
    Dougados, Maxime
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (01) : 25 - 33
  • [5] Doctor’s aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center
    Omar Al Tabaa
    Adrien Etcheto
    Sophie Dumas
    Frederic Batteux
    Claire Goulvestre
    Anna Moltó
    Corinne Miceli-Richard
    Maxime Dougados
    [J]. European Journal of Clinical Pharmacology, 2021, 77 : 25 - 33
  • [6] SWITCHING TO BIOSIMILAR ETANERCEPT IN CLINICAL PRACTICE
    Szlumper, Clare
    Topping, Karen
    Blackler, Laura
    Kirkham, Bruce
    Ng, Nora
    Cope, Andrew
    Agarwal, Sangita
    Garrood, Toby
    Mercer, Scott
    [J]. RHEUMATOLOGY, 2017, 56 : 139 - 139
  • [7] Treatment Continuation on the Etanercept Original in Comparison with a Biosimilar
    Baganz, Lisa
    Meissner, Yvette
    Herzer, Perter
    Braun, Juergen
    Graessler, Anett
    Strangfeld, Anja
    Zink, Angela
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] RETENTION RATES FOR ETANERCEPT: COMPARING THE ORIGINAL WITH A BIOSIMILAR
    Strangfeld, A.
    Baganz, L.
    Herzer, P.
    Braun, J.
    Graessler, A.
    Zink, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 315 - 315
  • [9] SWITCH FROM INNOVATOR ETANERCEPT TO BIOSIMILAR ETANERCEPT IN INFLAMMATORY RHEUMATIC DISEASES: THE EXPERIENCE OF COCHIN UNIVERSITY HOSPITAL PARIS-FRANCE.
    Al Tabaa, O.
    Etcheto, A.
    Miceli-Richard, C.
    Anna, M.
    Dougados, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 960 - 960
  • [10] WHAT FACTORS PREDICT GOOD PATIENT EXPERIENCES OF SWITCHING FROM REFERENCE ETANERCEPT TO AN ETANERCEPT BIOSIMILAR IN A SOUTH WEST LONDON GENERAL HOSPITAL?
    Attipoe, Laura
    Patel, Samir
    Bid, Robin
    Crooks, Jennifer
    Hunt, Kate
    Grigoriou, Antigoni
    [J]. RHEUMATOLOGY, 2018, 57